| Company Name | Exchange | Ticker | Market Cap (Mn) |
Last Price | Last Volume | Price Return (1-Day) |
Price Return (5-Days) |
52-Week High | 52-Week Low |
| Pinecrest Energy Inc | TSXV | PRY | 25.0 | 0.12 | 1,215,776 | 9.5% | 27.8% | 0.65 | 0.09 |
| Puma Biotechnology Inc | NYSE | PBYI | 7,030.4 | 233.43 | 8,190,016 | 295.4% | 263.8% | 241.42 | 33.70 |
Pinecrest Energy Inc (TSXV: PRY), formerly Antler Creek Energy Corp., a Canada-based junior oil and gas exploration company engaged in the acquisition, exploitation and development of petroleum and natural gas-related assets primarily in Western Sedimentary Basin, was among the top performers in the Canadian energy space after rallying 9.5% on Wednesday. The stock experienced a strong share price momentum after rallying over 9% in each of the last two consecutive days with strong trading volumes. The stock ended yesterday at C$0.12 while recording huge trading volumes of 1,215,776 shares. During the past 5-trading sessions, the stock gained 27.8% with 5-day average trading volumes of 584,048 shares compared to past one month daily average trading volumes of 416,949 shares.
Shares of Puma Biotechnology Inc (NYSE: PBYI), a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer, almost tripled during yesterday’s trading session after the announcement that the phase 3 trial testing neratinib in breast cancer patients was successful. The junior biotech stock skyrocketed 295.4% Wednesday breaching all the key technical resistance levels of 30-day, 50-day and 200-day DMAs at $68.30, $67.28 & $81.93 respectively. The stock ended at $233.43 while recording significant trading volumes of 8,190,016 shares. During the past five trading sessions, the stock gained 263.8% with daily average trading volumes of 2.2 million shares compared with the past one month average trading volumes of 672,567 shares. The stock is up 125.5% year-to-date.
